Raymond James upgraded ICU Medical (ICUI) to Strong Buy from Outperform with a price target of $97, down from $205. The firm believes the ...
Successful 2024 marked by significant clinical advancements across Oculis’ late-stage and highly differentiated clinical pipeline targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback